You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Dow
Mallinckrodt
Colorcon
McKinsey

Last Updated: February 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Rite Aid Corporation v. Endo Pharmaceuticals Inc. (N.D. Cal. 2015)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Rite Aid Corporation v. Endo Pharmaceuticals Inc. (N.D. Cal. 2015)

Docket   Start Trial Date Filed 2015-04-21
Court District Court, N.D. California Date Terminated 2018-09-20
Cause 15:25 Clayton Act Assigned To William Horsley Orrick III
Jury Demand Plaintiff Referred To
Parties ACTAVIS, PLC; ENDO PHARMACEUTICALS INC.; RITE AID CORPORATION; RITE AID HEADQUARTERS CORPORATION; TEIKOKU PHARMA USA; TEIKOKU PHARMA USA, INC.; TEIKOKU SEIYAKU CO; TEIKOKU SEIYAKU CO., LTD.; WATSON LABORATORIES, INC.; WATSON PHARMACEUTICALS, INC.
Patents 5,411,738; 5,601,838; 5,741,510; 5,827,529
Attorneys Anna Theresa Neill; Barry L. Refsin; Eric L Bloom; Monica L. Kiley; Monica L. Rebuck
Firms Hangley Aronchick Segal & Pudlin; Hangley Aronchick Segal Pudlin & Schiller; Hangley Aronchick Segal Pudlin Schiller
Link to Docket External link to docket
Small Molecule Drugs cited in Rite Aid Corporation v. Endo Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Rite Aid Corporation v. Endo Pharmaceuticals Inc. (N.D. Cal. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-04-21 1 listed three patents in the Orange Book. 26 52. The first was U.S. Patent No. 5,411,738 (the “‘738…Rolf patents -- the ‘333 patent, the ‘334 patent, and the ‘510 patent. Only the 2 ‘510 patent was listed… 26 Patent No. 5,536,263 (the “‘263 patent”), and U.S. Patent No. 5,741,510 (the “‘510 patent”), both…title to the ‘263 patent, the ‘510 patent, and three other patents. The three other patents were (i) 14 … U.S. Patent No. 6,096,333 (the “‘333 patent”), (ii) U.S. Patent No. 6,096,334 (the “‘334 patent”), 15 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Dow
Boehringer Ingelheim
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.